Origin Medsystems, Inc. (extinct)

Origin Medsystems, Inc. (extinct)

Origin Medsystems, Inc. (extinct)

Overview
Headquarters

135 Constitution Drive,Menlo Park, CA 94025

Type of Company

Private

Industries

Aerospace & Defense
Medical Products & Equipment
Hospitals & Patient Services

Company Description

Origin Medsystems, Inc., is a manufacturer of the products used in hernia repair surgery. This company is a subsidiary of Eli Lilly & Co.

Paths to Origin Medsystems, Inc.
Potential Connections via
Relationship Science
You
Origin Medsystems, Inc.
Recent Transactions
Details Hidden

Eli Lilly & Company purchases Origin Medsystems, Inc. from Domain Associates LLC, NEA Management Co. LLC

Advisors & Consultants
Legal Advisor

Partner at Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Legal Advisor

Partner at Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Investors
Details Hidden

Founder at Auris Surgical Robotics, Inc.

Details Hidden

New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.

Details Hidden

Domain Associates invests exclusively in emerging life sciences companies. The firm focuses on pharmaceuticals, specialty pharmaceuticals and medical devices and they are also interested in biomaterials, bioinstrumentation and diagnostics. They prefer to be part of the first institutional financing round of a company. They look for companies with outstanding technology addressing unmet needs in very large markets led by exceptional management. Once invested, Domain takes an active role in guiding the growth of the company. They take a seat on the Board of Directors in the vast majority of cases. Most of their investments are in private companies, but they also invest in small-cap public healthcare companies that are implementing a new corporate strategy.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Origin Medsystems, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Origin Medsystems, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Origin Medsystems, Inc..